A randomised, double blind, multi centre, placebo controlled dose escalation study in healthy subjects investigating the safety, tolerability and pharmacokinetic properties of the study drug, followed by an expansion cohort treating subjects with idiopathic pulmonary fibrosis (IPF).
Back to Resource Center